miRNA expression in anaplastic thyroid carcinomas

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Heb́rant, Aline ^a   Floor, Sébastien ^a   Saiselet, Manuel ^a   Antoniou, Aline ^a   Desbuleux, Alice ^a   Snyers, Béreng̀ere ^a   La, Caroline ^a   Aubain, Nicolas De Saint ^b   Leteurtre, Emmanuelle ^c,d   Andry, Guy ^b   Maenhaut, Carine ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b JULES BORDET INSTITUTE   (Belgium)

^c UNIV LILLE   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LET 7G; MICRORNA; MICRORNA 125B; MICRORNA 144; MICRORNA 29A; MICRORNA 30A; MICRORNA 30E; MICRORNA 34B; MICRORNA 514; MICRORNA 659; UNCLASSIFIED DRUG; MESSENGER RNA; MIRN29 MICRORNA, HUMAN; TUMOR MARKER;

ADENOMA; ARTICLE; AUTONOMOUS ADENOMA; BIOINFORMATICS; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE INTERACTION; HEK293 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; LOX GENE; LUCIFERASE ASSAY; MICROARRAY ANALYSIS; PARACRINE SIGNALING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; UPREGULATION; BIOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; THYROID GLAND; THYROID TUMOR;

COMPUTATIONAL BIOLOGY; DNA MUTATIONAL ANALYSIS; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION; MICRORNAS; RNA, MESSENGER; THYROID CARCINOMA, ANAPLASTIC; THYROID GLAND; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84929508623     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103871     Document Type: Article

References (41)

1. Smallridge RC, Marlow LA, Copland JA (2009) Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies. Endocr Relat Cancer 16: 17-44.
2. Ain KB (1999) Anaplastic thyroid carcinoma: a therapeutic challenge. Semin Surg Oncol 16: 64-69.
3. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC (2011) Anaplastic thyroid cancer: a review of epidemiology, pathogenesis, and treatment. J Oncol 2011: 542358.
4. Are C, Shaha AR (2006) Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches. Ann Surg Oncol 13: 453-464.
5. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, et al. (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16: 109-142.
6. Caillou B, Talbot M, Weyemi U, Pioche-Durieu C, Al GA, et al. (2011) Tumor-associated macrophages (TAMs) form an interconnected cellular supportive network in anaplastic thyroid carcinoma. PLoS One 6: e22567. 10.1371/journal.pone.0022567 [doi];PONE-D-10-05881 [pii].
7. Kim S, Cho SW, Min HS, Kim KM, Yeom GJ, et al. (2013) The expression of tumor-associated macrophages in papillary thyroid carcinoma. Endocrinol Metab (Seoul) 28: 192-198. 10.3803/EnM.2013.28.3.192 [doi].
8. Ryder M, Ghossein RA, Ricarte-Filho JC, Knauf JA, Fagin JA (2008) Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer. Endocr Relat Cancer 15: 1069-1074. ERC-08-0036 [pii];10.1677/ERC-08-0036 [doi].
9. Qing W, Fang WY, Ye L, Shen LY, Zhang XF, et al. (2012) Density of tumor-associated macrophages correlates with lymph node metastasis in papillary thyroid carcinoma. Thyroid 22: 905-910. 10.1089/thy.2011.0452 [doi].
10. Hebrant A, Dom G, Dewaele M, Andry G, Tresallet C, et al. (2012) mRNA expression in papillary and anaplastic thyroid carcinoma: molecular anatomy of a killing switch. PLoS One 7: e37807.
11. He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5: 522-531. 10.1038/nrg1379 [doi];nrg1379 [pii].
12. Kiriakidou M, Nelson PT, Kouranov A, Fitziev P, Bouyioukos C, et al. (2004) A combined computational-experimental approach predicts human microRNA targets. Genes Dev 18: 1165-1178. (Pubitemid 38669037)
13. Bagga S, Bracht J, Hunter S, Massirer K, Holtz J, et al. (2005) Regulation by let- 7 and lin-4 miRNAs results in target mRNA degradation. Cell 122: 553-563. (Pubitemid 41191154)
14. Du T, Zamore PD (2005) microPrimer: the biogenesis and function of microRNA. Development 132: 4645-4652. (Pubitemid 41685275)
15. Djuranovic S, Nahvi A, Green R (2011) A parsimonious model for gene regulation by miRNAs. Science 331: 550-553.
16. Guo H, Ingolia NT, Weissman JS, Bartel DP (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466: 835-840.
17. Wang X, El Naqa IM (2008) Prediction of both conserved and nonconserved microRNA targets in animals. Bioinformatics 24: 325-332. (Pubitemid 351189007)
18. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
19. Nielsen BS, Jorgensen S, Fog JU, Sokilde R, Christensen IJ, et al. (2011) High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients. Clin Exp Metastasis 28: 27-38. 10.1007/s10585-010-9355-7 [doi].
20. Braun J, Hoang-Vu C, Dralle H, Huttelmaier S (2010) Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas. Oncogene 29: 4237-4244.
21. Visone R, Pallante P, Vecchione A, Cirombella R, Ferracin M, et al. (2007) Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene 26: 7590-7595. (Pubitemid 350207711)
22. Pallante P, Battista S, Pierantoni GM, Fusco A (2014) Deregulation of microRNA expression in thyroid neoplasias. Nat Rev Endocrinol 10: 88-101. nrendo.2013.223 [pii];10.1038/nrendo.2013.223 [doi].
23. Schietke R, Warnecke C, Wacker I, Schodel J, Mole DR, et al. (2010) The lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia: insights into cellular transformation processes mediated by HIF-1. J Biol Chem 285: 6658-6669. M109.042424 [pii];10.1074/jbc.M109.042424 [doi].
24. Hammond SM (2006) MicroRNAs as oncogenes. Curr Opin Genet Dev 16: 4-9.
25. Liu CY, Xu JY, Shi XY, Huang W, Ruan TY, et al. (2013) M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway. Lab Invest 93: 844-854. labinvest201369 [pii];10.1038/labinvest.2013.69 [doi].
26. Bonde AK, Tischler V, Kumar S, Soltermann A, Schwendener RA (2012) Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors. BMC Cancer 12: 35. 1471-2407-12-35 [pii];10.1186/1471-2407-12-35 [doi].
27. Baay M, Brouwer A, Pauwels P, Peeters M, Lardon F (2011) Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy. Clin Dev Immunol 2011: 565187. 10.1155/2011/565187 [doi].
28. Yang J, Weinberg RA (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14: 818-829. (Pubitemid 351757205)
29. Aigner A (2011) MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs. J Mol Med.
30. Dykxhoorn DM, Wu Y, Xie H, Yu F, Lal A, et al. (2009) miR-200 enhances mouse breast cancer cell colonization to form distant metastases. PLoS One 4: e7181.
31. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, et al. (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10: 593-601. (Pubitemid 351627379)
32. Sayed D, Abdellatif M (2011) MicroRNAs in development and disease. Physiol Rev 91: 827-887.
33. Varambally S, Cao Q, Mani RS, Shankar S, Wang X, et al. (2008) Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 322: 1695-1699.
34. Cao Q, Yu J, Dhanasekaran SM, Kim JH, Mani RS, et al.(2008) Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene 27: 7274-7284.
35. Watanabe S, Ueda Y, Akaboshi S, Hino Y, Sekita Y, et al. (2009) HMGA2 maintains oncogenic RAS-induced epithelial-mesenchymal transition in human pancreatic cancer cells. Am J Pathol 174: 854-868.
36. Guo L, Chen C, Shi M, Wang F, Chen X, et al.(2013) Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition. Oncogene 32: 5272-5282. onc2012573 [pii];10.1038/onc.2012.573 [doi].
37. Chen Z, Cheng Q, Ma Z, Xi H, Peng R, et al. (2013) Overexpression of RKIP Inhibits Cell Invasion in Glioma Cell Lines through Upregulation of miR-98. Biomed Res Int 2013: 695179. 10.1155/2013/695179 [doi].
38. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, et al. (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451: 147-152. nature06487 [pii];10.1038/nature06487 [doi].
39. Png KJ, Yoshida M, Zhang XH, Shu W, Lee H, et al. (2011) MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer. Genes Dev 25: 226-231. 25/3/226 [pii];10.1101/gad.1974211 [doi].
40. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518.
41. Ryder M, Gild M, Hohl TM, Pamer E, Knauf J, et al. (2013) Genetic and pharmacological targeting of CSF-1/CSF-1R inhibits tumor-associated macrophages and impairs BRAF-induced thyroid cancer progression. PLoS One 8: e54302. 10.1371/journal.pone.0054302 [doi];PONE-D-12-29549 [pii].